Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote

Fri, 20th Dec 2019 12:09

(Alliance News) - Stocks in London were mixed at midday on Friday as investors look ahead to the Brexit deal vote in Parliament in the afternoon, while the UK chancellor finally named a new governor of the Bank of England.

The FTSE 100 index was up 16.90 points, or 0.2% at 7,589.97. The mid-cap FTSE 250 index was down 60.96 points, or 0.3% at 21,605.18, and the AIM All-Share index was 0.4% higher at 941.63.

The Cboe UK 100 index was up 0.2% at 12,865.61. The Cboe 250 was 0.2% lower at 19,518.94, and the Cboe Small Companies was down 0.2% at 12,030.27.

In mainland Europe, the CAC 40 in Paris was up 0.5% and the DAX 30 in Frankfurt was up 0.6%.

"UK stocks are treading water as they eagerly await the next step in the Brexit process today. With Theresa May and Boris Johnson previously unable to pass their respective withdrawal agreements, the value of a strong parliamentary majority will become clear today as Johnson's deal looks set to sail through without a hitch. For markets this should provide some degree of certainty and confidence, yet we are instead seeing anxiety remain thanks to Johnson's hard deadline of December 2020 to conclude trade negotiations," said IG Group's Josh Mahony.

In the FTSE 100, AstraZeneca was up 1.5% after the Anglo-Swedish drugmaker said it divested the rights to cancer drugs Arimidex and Casodex in a number of countries to Juvise Pharmaceuticals for up to USD198 million.

At the other end of the large cap index, NMC Health was by far the worst performer, down 21%. The Financial Times on Friday reported the UAE-focused private healthcare firm held talks to raise EUR200 million of off-balance sheet debt to fund new hospitals.

NMC has come under increased scrutiny from analysts, investors and short-sellers this year about its apparent use of off-balance sheet financing, that does not count toward its official debt levels.

NMC shares dropped on Tuesday after short selling firm Muddy Waters Capital said it had shorted the stock, commenting: "We have serious doubts about the company's financial statements, including its asset values, cash balance, reported profit, and reported debt levels."

NMC on Thursday hit back saying the Muddy Waters report was "false" and "misleading".

NMC shares have almost halved in value this week.

Royal Dutch Shell 'A' and 'B' shares were down 1.2% on Friday, after the oil major guided for a potential impairment based on "the macro outlook".

Shell is to book a post-tax impairment of USD1.7 billion to USD2.3 billion for the fourth-quarter of 2019, based on macroeconomic conditions, without giving any further details. The oil giant, London's largest listed company by market capitalisation, guided for a number of other charges which are set to hit fourth-quarter earnings.

In the Upstream unit, Shell will book USD100 million to USD200 million in charges related to well write-offs, plus a USD500 million to USD600 million deferred tax charge. Production in the segment for the last quarter of 2019 is guided between 2.78 million and 2.83 million barrels of oil equivalent per day. Production in all of 2018 was around 2.7 million barrels a day.

Still to come in the UK corporate calendar, Anglo-US cruise line operator Carnival is expected to report annual earnings this afternoon.

The pound was quoted at USD1.3035 at midday, slightly higher than USD1.3015 late Thursday, after UK economic growth in the third-quarter was revised upwards, the Office for National Statistics revealed.

Third-quarter gross domestic product expanded 0.4% from the second quarter, the ONS said, having previously reported a quarter-on-quarter figure of 0.3%. The ONS also reported a higher annual growth figure, with GDP in the third quarter rising by 1.1% compared to the prior estimate of 1.0%. Services remain the main contributor to growth, the ONS said, with construction also contributing positively.

Meanwhile, the head of the UK financial watchdog Andrew Bailey has been chosen as the next governor of the Bank of England, the Treasury announced.

Bailey's tenure at the BoE will begin on March 16 next year and will succeed Canadian Mark Carney, who took up the role in 2013. Carney has since extended his tenure twice, the second time to avoid any disruption during the UK's talks to leave the EU.

Bailey has been head of the Financial Conduct Authority since July 2016. Before that, he was chief executive of the Prudential Regulation Authority.

As part of his general election pledge to have Brexit "decided" by Christmas, UK Prime Minister Boris Johnson will bring back the EU Withdrawal Agreement Bill for its second reading in the House of Commons on Friday.

After the Conservatives won a landslide at the general election and secured an 80-seat majority last week, the vote in the afternoon is expected to pass without a hitch for the government and lay the ground for a January exit from the EU.

The euro stood at USD1.1094 at midday, down from USD1.1111 late Thursday. Against the yen, the dollar was trading at JPY109.35, firm from JPY109.28 late Thursday.

Stocks in New York were set for a subdued open on Friday. All three major US stock indices set fresh highs on Thursday amid a cooling of US-China trade tensions and a new continental trade agreement among the US, Canada and Mexico advancing in Congress.

The DJIA was called called up 0.1%, the S&P 500 index called flat and the Nasdaq Composite up 0.1%.

Ahead in the economic events calendar, there are US third-quarter GDP figures at 1330 GMT.

Brent oil was quoted at USD66.22 a barrel at the equities close, soft against USD66.50 late Thursday.

Gold was quoted at USD1,477.30 an ounce at the London equities close, little changed USD1,476.20 late Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

London market Midday is available to subscribers as an email newsletter. Contact info@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.